PlainRecalls
FDA Drug Low Class III Terminated

Ciprofloxacin in Dextrose (5%) Injection, USP 200 mg in 100 mL 5% Dextrose, Rx Only, (2 mg/mL), 100 mL Flexible Bag, Manufactured for: Claris LifeScience Inc. North Brunswick NJ 08902 by Claris Injectables Ltd. Gujarat, India UPC 336000008242 NDC 36000-008-249

Reported: December 27, 2017 Initiated: November 6, 2017 #D-0127-2018

Product Description

Ciprofloxacin in Dextrose (5%) Injection, USP 200 mg in 100 mL 5% Dextrose, Rx Only, (2 mg/mL), 100 mL Flexible Bag, Manufactured for: Claris LifeScience Inc. North Brunswick NJ 08902 by Claris Injectables Ltd. Gujarat, India UPC 336000008242 NDC 36000-008-249

Reason for Recall

Superpotent

Details

Recalling Firm
Claris Lifesciences Inc
Distribution
Nationwide
Location
North Brunswick, NJ

Frequently Asked Questions

What product was recalled?
Ciprofloxacin in Dextrose (5%) Injection, USP 200 mg in 100 mL 5% Dextrose, Rx Only, (2 mg/mL), 100 mL Flexible Bag, Manufactured for: Claris LifeScience Inc. North Brunswick NJ 08902 by Claris Injectables Ltd. Gujarat, India UPC 336000008242 NDC 36000-008-249. Recalled by Claris Lifesciences Inc.
Why was this product recalled?
Superpotent
Which agency issued this recall?
This recall was issued by the FDA Drug on December 27, 2017. Severity: Low. Recall number: D-0127-2018.